MidAtlantic Retina

Bethlehem, Pennsylvania 18107

3 studies enrolling now · 13 studies all time

What they study most

Age-related Macular Degeneration (AMD), Central Serous Chorioretinopathy, Diabetic Macular Edema, Geographic Atrophy, Geographic Atrophy (GA), Geographic Atrophy Secondary to Age-related Macular Degeneration, Geographic Atrophy of the Macula, Intravitreal Injection, Macular Degeneration, Macular Neovascularization Secondary to Age-Related Macular Degeneration, Neovascular (Wet) Age-Related Macular Degeneration, Neovascular Age-Related Macular Degeneration

Studies at this site

• A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) — Recruiting now
• A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy — Recruiting now
• 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration — Recruiting now
• An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD — Completed
• 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration — Running, not enrolling
• A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) — Running, not enrolling
• A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME) — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR) — Stopped early
• The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME) — Completed
• Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection. — Completed
• A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed
• The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) — Completed
• Eplerenone for the Treatment of Central Serous Chorioretinopathy — Completed